Plus Therapeutics’ (PSTV) Buy Rating Reaffirmed at HC Wainwright
Plus Therapeutics (NASDAQ:PSTV – Get Free Report)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $8.00 price objective on the stock. Separately, Ascendiant Capital Markets dropped their price target on Plus Therapeutics from $21.00 to $20.00 […]
More Stories
Is The Amazing Digital Circus Renewed? Know about its Release Date
Are you also a fan of adult anime shows? Good news, everyone’s favourite fantasy drama, The Amazing Digital Circus, aka...
Tex Mex Motors Season 3 Updates and Renewal Details
The 2023 premiere series, Tex Mex Motors, is a reality TV show. The series has 2 seasons with episodes showing...
Grown Ups 3: Release Date, Cast Members, and Trailer Updates
About 16 years after its release, the comedy film Grown Ups is finally getting a sequel. The famous group of...
Ripe for the Picking Season 2: Release Date, Cast, and More
Ripe for the Picking is a Japanese manga series. It was first released as a magazine before becoming a web...
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...
Let’s Talk About Chu Season 2: Release Date, Cast, and More
The romantic-comedy Taiwanese series Let’s Talk About Chu has become one of the most talked-about series since its release in...